GTR Home > Tests > Search results - Short QT syndrome 1

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1865020[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 37 tests for 1 condition in 17 labs

CShort QT syndrome type 1

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region

CKCNH2 mutation analysis

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLong QT Syndrome via the KCNH2 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CCardiomyopathy and Arrhythmia Panel, Sequencing (85 Genes) and Deletion/Duplication (83 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CCardiomyopathy and Arrhythmia Deletion/Duplication, 83 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Total conditions (151)
Total targets (83)

CCardiomyopathy and Arrhythmia Panel, Sequencing, 85 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CShort QT Syndrome 1

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CShort QT Syndrome 1

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CComprehensive Cardiac Channelopathy Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (35)
Total targets (22)

CKCNH2

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CShort QT syndrome

Lab: Invitae San Francisco, California, United States
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (6)

CKCNQ1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CShort QT syndrome

Lab: Synlab MVZ Humane Genetik München München, Bayern, Germany
Test targets
Methods
  • S Mutation scanning of the entire coding region

CKCNJ2. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CKCNE1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSCN5A. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CKCNE2. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CKCNH2. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CKCNH2, KCNJ2, KCNQ1. NextGeneDx.Complete sequencing by NGS

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 37 tests for 1 condition in 17 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.